Maya Solovitz, a science and public policy reporter and author of "Undoing Drugs," teams up with Ziva Cooper, UCLA’s cannabis expert, to discuss the surge in cannabis use, now surpassing alcohol. They explore the implications of this trend, including health impacts and changing social acceptance. The duo tackles the complexities of cannabis research, facing regulatory hurdles, and debates the ethics and effects of growing potency. Lastly, they call for a reevaluation of cannabis classifications, arguing for evidence-based regulations.
The significant rise in daily cannabis use, now surpassing alcohol, highlights changing societal attitudes and increasing accessibility since 1979.
The urgent need for updated research on cannabis potency and long-term health effects is hindered by its current classification as a Schedule 1 drug.
Deep dives
The Rise of Daily Cannabis Use
Daily marijuana use in the United States has become more prevalent than daily alcohol consumption. Recent data reveals a significant increase in per capita daily and near-daily cannabis users, which has risen 15-fold since 1979. Around 17.7 million Americans now consume marijuana almost daily, reflecting changing societal attitudes and diminished legal risks associated with cannabis. Despite still having more alcohol users in absolute numbers, the cultural acceptance and accessibility of marijuana have contributed to its rising popularity.
Impact of Price and Potency
The decline in the price of THC per milligram has transformed cannabis from a luxury into a consumer good, leading to increased consumption. Reports indicate that the price of cannabis has dropped by up to 80% since 2008, encouraging more users to partake regularly. In addition, cannabis has evolved in potency, with products now averaging much higher concentrations of THC than in previous decades. This combination of lower costs and higher potency challenges current understanding of consumption effects on health.
Health Implications and Research Gaps
There is a notable gap in research regarding the behavioral and health consequences of increased cannabis potency and frequent use. Studies have generally measured lower doses of THC, often under 40 milligrams, while average daily users may consume around 320 milligrams. This discrepancy raises concerns about potential risks associated with higher-intensity cannabis products. As the volume and strength of cannabis usage grow, the need for comprehensive studies regarding its long-term effects has become increasingly urgent.
Regulatory Challenges and Future Directions
The current classification of marijuana as a Schedule 1 drug creates significant barriers for research and regulation. Many experts advocate for reclassification to Schedule 3, which would acknowledge its medical uses and potentially ease research restrictions. However, regulatory challenges persist in ensuring product safety and quality in the rapidly evolving landscape of cannabis consumption. Moving forward, establishing robust frameworks for cannabis regulation and research is crucial to balance public safety with the growing acceptance of marijuana.
Americans are now more likely to use cannabis than alcohol on a daily basis. But as cannabis use continues to climb, are research and policies keeping up?
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode